The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor.

BACKGROUND

Previous studies have shown that metabolic dysfunction associated fatty liver disease (MAFLD) is associated with thyroid hormones (THs), immunity, and inflammation status, but few studies involved thyroid autoimmunity. This study aimed to evaluate the role of THs, thyroid autoantibodies, inflammatory biomarkers in MAFLD, its cofactors, and other possible determinants.

MATERIALS AND METHODS

In the study, a total of 424 Chinese patients were selected and categorized as non-MAFLD and MAFLD. Serum thyroid hormone, thyroid autoantibody and high-sensitive C-reactive protein (hsCRP) levels were measured. The data of blood pressure, the serum lipid profile, glucose and liver enzymes were collected. The differences and association between research findings were examined and analyzed by Wilcoxon Signed Rank Test, One-Way ANOVA test and Multiple Logistic Regression models.

RESULTS

The study showed significant increase in the prevalence of MAFLD with high thyroid stimulating hormone (TSH) levels ( < 0.01) and abnormal high-sensitive C-reactive protein (hsCRP) levels ( < 0.01). The proportion of MAFLD patients decreased significantly with the rise of free thyroxine (FT4) ( = 0.04), thyrotropin receptor antibodies (TRAb) ( < 0.01), anti-thyroglobulin antibodies (TgAb) ( < 0.01), and thyroid peroxidase antibodies (TPOAb) levels ( < 0.01). Based on logistic regression analysis, MAFLD was significantly associated with lower levels of TgAb ( < 0.01), TPOAb ( < 0.01), and higher levels of hsCRP ( < 0.01) in male. In female, elevated TgAb ( < 0.01) may be a protective factor, while higher levels of hsCRP ( < 0.01) showed increased risk of MAFLD. Logistic models were adjusted for age, BMI, SBP, DBP, FBG, ALT, AST, TC, TG, LDL, HDL.

CONCLUSIONS

Taken together, TgAb may be a potential protective factor for MAFLD and elevated hsCRP level should be considered as an independent risk factor for MAFLD in both genders. TPOAb also demonstrated protective effect, but only in male. The prevalence of MAFLD increased with higher TSH levels and lower FT4, TRAb levels, but no significant association were found. However, Our findings provide a new insight into the pathogenesis of MAFLD by further investigating the impact of THs, thyroid autoimmunity, and inflammation on MAFLD patients.